(Q51947105)

18 April 2018

title

NK cells: new issues and challenges. Preface. (English)

1 reference

18 April 2018

author

Marco Colonna

series ordinal

1

1 reference

18 April 2018

language of work or name

English

0 references

publication date

1 November 2008

1 reference

18 April 2018

European Journal of Immunology

published in

1 reference

18 April 2018

volume

38

1 reference

18 April 2018

issue

11

1 reference

18 April 2018

page(s)

2927-2929

1 reference

18 April 2018

Functionally distinct NK-cell subsets: developmental origins and biological implications

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Non-cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Killers and beyond: NK-cell-mediated control of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

NK cells and Treg cells: a fascinating dance cheek to cheek

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Can NK cells be a therapeutic target in human type 1 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

NK3-like NK cells are involved in protective effect of polyinosinic-polycytidylic acid on type 1 diabetes in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Beyond licensing and disarming: a quantitative view on NK-cell education

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Can NK cells be a therapeutic target in human cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Evolutionary struggles between NK cells and viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

NK cells promote islet allograft tolerance via a perforin-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Critical role for IFN-γ in natural killer cell-mediated protection from diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Target cell defense prevents the development of diabetes after viral infection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

How do natural killer cells find self to achieve tolerance?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Self-tolerance of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838883

7 January 2021

Identifiers

DOI

10.1002/EJI.200838883

1 reference

18 April 2018

1 reference

18 April 2018